Insights

Early-stage financing Interline Therapeutics recently closed a substantial $92M financing round led by prominent investors, indicating strong investor confidence and potential for collaboration on funded discovery programs.

Foresite Labs affiliation As a Foresite Labs incubated company, Interline has access to an accelerator ecosystem, potential co-development opportunities, and credibility that can open doors with large pharma partners seeking innovative gene or protein community–driven targets.

Cancer and inflammation focus The company's emphasis on cancer and inflammatory diseases highlights priority therapeutic areas where partner pipelines, tool development, or joint discovery programs could align with BD and licensing discussions.

Robust cloud stack Operations rely on major cloud and data tools (AWS, Google Cloud, Kubernetes, Docker, Airflow, PostgreSQL), suggesting readiness for scalable data collaboration, computational biology projects, and secure hosted data partnerships.

Small team, scalable model With a lean staff and a strong funding base, there could be opportunities to provide specialized outsourcing, CRO-style discovery services, or platform-enabled collaborations to accelerate their research without massive headcount increases.

Similar companies to Interline Therapeutics

Interline Therapeutics Tech Stack

Interline Therapeutics uses 8 technology products and services including Amazon Web Services, GitHub, Apache Airflow, and more. Explore Interline Therapeutics's tech stack below.

Interline Therapeutics's Email Address Formats

Interline Therapeutics uses at least 1 email format:
Interline Therapeutics Email FormatsExamplePercentage
FLast@interlinetx.comJDoe@interlinetx.com
100%

Frequently Asked Questions

What is Interline Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Interline Therapeutics's official website is interlinetx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Interline Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Interline Therapeutics's annual revenue is estimated to be <$1M.

What is Interline Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Interline Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Interline Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Interline Therapeutics has approximately 2 employees across 2 continents, including North America and Europe. Key team members include Founder: Z. S., Principal Scientist: D. B. and Principal Scientist: L. N. Explore Interline Therapeutics's employee directory with LeadIQ.

What industry does Interline Therapeutics belong to?

Minus sign iconPlus sign icon
Interline Therapeutics operates in the Biotechnology Research industry.

What technology does Interline Therapeutics use?

Minus sign iconPlus sign icon
Interline Therapeutics's tech stack includes Amazon Web Services, GitHub, Apache Airflow, Docker, Kubernetes, PostgreSQL, Microsoft 365 and Google Cloud.

What is Interline Therapeutics's email format?

Minus sign iconPlus sign icon
Interline Therapeutics's email format typically follows the pattern of FLast@interlinetx.com. Find more Interline Therapeutics email formats with LeadIQ.

How much funding has Interline Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Interline Therapeutics has raised $92M in funding. The last funding round occurred on May 13, 2021 for $60M.

When was Interline Therapeutics founded?

Minus sign iconPlus sign icon
Interline Therapeutics was founded in 2020.
Interline Therapeutics logo

Interline Therapeutics

Biotechnology ResearchCalifornia, United States2-10 Employees

Interline Therapeutics is a biotechnology research company focused on mapping protein communities to uncover molecular mechanisms of disease, with the aim of identifying new medicines for cancer and inflammatory conditions. Based in Brisbane, California, the company operates in a research-focused niche within the biotechnology sector and is positioned to address complex disease biology through systematic study of protein networks. Its work targets drug discovery for serious diseases, translating structural and functional insights into potential therapeutic candidates for clinical development. The firm is part of a broader ecosystem of science-driven, incubator-linked ventures in the San Francisco Bay Area, with recent activity linked to its role in launching and collaborating within the Foresite Labs ecosystem. Interline Therapeutics is headquartered in Brisbane, and operates with a small team focused on research and discovery priorities as part of its existing strategic collaborations.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • $92M

    Interline Therapeutics has raised a total of $92M of funding over 2 rounds. Their latest funding round was raised on May 13, 2021 in the amount of $60M as a Series A.

  • <$1M

    Interline Therapeutics's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.